$BIVI
BIOVIE INC. Stock $bivi

$bivi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000152013823000473 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.254M	$1.943M	$2.007M
YoY Change	-48.83%	-3.2%	-24.1%
% of Gross Profit
Research & Development	$6.470M	$8.876M	$6.770M
YoY Change	-8.0%	31.1%	137.91%
% of Gross Profit
Depreciation & Amortization	$54.69K	$60.00K	$57.34K
YoY Change	-4.64%	4.64%	0.0%
% of Gross Profit
Operating Expenses	$8.781M	$10.88M	$8.834M
YoY Change	-23.61%	23.11%	59.26%
Operating Profit	-$8.781M	-$10.88M	-$8.834M
YoY Change	-23.61%	23.11%	59.26%
Interest Expense	$820.6K	$1.005M	$1.056M
YoY Change	-22.1%	-4.9%	16053.15%
% of Operating Profit
Other Income/Expense, Net	$380.0K	$165.4K
YoY Change	-109.06%
Pretax Income	-$8.401M	-$10.71M	-$10.42M
YoY Change	-46.44%	2.83%	87.98%
Income Tax
% Of Pretax Income
Net Earnings	-$8.401M	-$10.71M	-$10.42M
YoY Change	-46.44%	2.83%	87.98%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.22	-$0.29	-$0.38
Diluted Earnings Per Share	-$0.22	-$0.29	-$0.38
COMMON SHARES
Basic Shares Outstanding	37.74M shares	36.80M shares	30.17M shares
Diluted Shares Outstanding	38.17M shares	36.74M shares	27.21M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.23M	$21.21M	$21.23M
YoY Change	-55.79%	-0.1%	3.63%
Cash & Equivalents	$20.23M	$21.21M	$21.23M
Short-Term Investments		$0.00
Other Short-Term Assets	$335.0K	$1.550M	$359.1K
YoY Change	38.83%	331.61%	239.05%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$20.56M	$22.76M	$21.59M
YoY Change	-55.29%	5.44%	4.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$60.42K	$70.00K	$109.3K
YoY Change	-39.6%	-35.94%
Goodwill	$345.7K	$345.7K	$345.7K
YoY Change	0.0%	0.0%
Intangibles	$522.4K	$579.8K	$809.1K
YoY Change	-30.51%	-28.35%
Long-Term Investments
YoY Change
Other Assets			$4.562K
YoY Change
Total Long-Term Assets	$928.5K	$996.2K	$1.269M
YoY Change	-22.76%	-21.48%	-8.35%
TOTAL ASSETS
Total Short-Term Assets	$20.56M	$22.76M	$21.59M
Total Long-Term Assets	$928.5K	$996.2K	$1.269M
Total Assets	$21.49M	$23.76M	$22.86M
YoY Change	-54.46%	3.94%	4.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.608M	$2.715M	$2.622M
YoY Change	11.18%	3.52%	285.98%
Accrued Expenses	$48.23K	$50.00K	$40.32K
YoY Change	15.41%	24.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.20M	$9.340M
YoY Change
Total Short-Term Liabilities	$13.98M	$13.21M	$4.096M
YoY Change	79.32%	222.59%	225.04%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$2.970M	$12.73M
YoY Change	-100.0%	-76.66%
Other Long-Term Liabilities	$17.60K	$30.00K
YoY Change
Total Long-Term Liabilities	$17.60K	$3.000M	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.98M	$13.21M	$4.096M
Total Long-Term Liabilities	$17.60K	$3.000M	$0.00
Total Liabilities	$14.00M	$16.21M	$16.90M
YoY Change	-33.73%	-4.06%	868.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$320.3M	-$311.9M	-$261.4M
YoY Change	15.62%	19.34%
Common Stock	$327.8M	$319.5M	$267.3M
YoY Change	8.14%	19.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.00	$2.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.491M	$7.548M	$5.961M
YoY Change
Total Liabilities & Shareholders Equity	$21.49M	$23.76M	$22.86M
YoY Change	-54.46%	3.94%	4.01%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$8.401M	-$10.71M	-$10.42M
YoY Change	-46.44%	2.83%	87.98%
Depreciation, Depletion And Amortization	$54.69K	$60.00K	$57.34K
YoY Change	-4.64%	4.64%	0.0%
Cash From Operating Activities	-$5.907M	-$12.18M	-$9.220M
YoY Change	-26.25%	32.07%	263.77%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$5.000K	$14.53M
YoY Change
Cash From Investing Activities	-$5.000K	$14.53M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.918M	-$594.2K	$11.81M
YoY Change	-84.88%	-105.03%	-36.2%
NET CHANGE
Cash From Operating Activities	-5.907M	-$12.18M	-$9.220M
Cash From Investing Activities	-5.000K	$14.53M
Cash From Financing Activities	4.918M	-$594.2K	$11.81M
Net Change In Cash	-994.2K	$1.754M	$2.589M
YoY Change	-104.05%	-32.27%	-83.79%
FREE CASH FLOW
Cash From Operating Activities	-$5.907M	-$12.18M	-$9.220M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001580149
CY2022Q3	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement		usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q3	bivi	Maturity Of U.S.Treasury Bills MaturityOfU.s.TreasuryBills		usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q3	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty		usd
CY2022Q3	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement		usd
CY2023Q3	bivi	Issuance Of Common Stock From Vesting Of Restricted Stock Units IssuanceOfCommonStockFromVestingOfRestrictedStockUnits		usd
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	001-39015
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	BIOVIE INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2510769
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	680 W Nye Lane
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 204
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Carson City
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89703
CY2023Q3	dei	City Area Code CityAreaCode	775
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	888-3162
CY2023Q3	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
CY2023Q3	dei	Trading Symbol TradingSymbol	BIVI
CY2023Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37742695	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21214670	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19460883	usd
CY2023Q2	bivi	Investments In U.S.Treasury Bills InvestmentsInU.s.TreasuryBills	14477726	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1549287	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	102526	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	22763957	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	34041135	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	70748	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80789	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	579751	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	637095	usd
CY2023Q3	us-gaap	Goodwill Goodwill	345711	usd
CY2023Q2	us-gaap	Goodwill Goodwill	345711	usd
CY2023Q3	us-gaap	Assets Assets	23760167	usd
CY2023Q2	us-gaap	Assets Assets	35104730	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2714760	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3476259	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48385	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	46548	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44909	usd
CY2023Q3	bivi	Unearned Premium Anddiscount Current UnearnedPremiumAnddiscountCurrent	661467	usd
CY2023Q2	bivi	Unearned Premium Anddiscount Current UnearnedPremiumAnddiscountCurrent	894926	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	9338533	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	9105074	usd
CY2023Q3	bivi	Warrant Liabilities WarrantLiabilities	622397	usd
CY2023Q2	bivi	Warrant Liabilities WarrantLiabilities	894280	usd
CY2023Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	489843	usd
CY2023Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	925762	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13212081	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14494669	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30221	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42505	usd
CY2023Q3	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	469937	usd
CY2023Q2	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	227270	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	2969937	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	5227270	usd
CY2023Q3	us-gaap	Liabilities Liabilities	16212239	usd
CY2023Q2	us-gaap	Liabilities Liabilities	19764444	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36922760	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36899880	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36451829	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36428949	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	3690	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3643	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	319480409	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	316385759	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	176591	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-311936169	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301225705	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7547928	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15340286	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23760167	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35104730	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8875659	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6769932	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1942818	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2007062	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	10875821	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	8834338	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10875821	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8834338	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	707802	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-566542	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1004668	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1056416	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	462223	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	41585	usd
CY2023Q3	bivi	Total Other Expense Income TotalOtherExpenseIncome	-165357	usd
CY2022Q3	bivi	Total Other Expense Income TotalOtherExpenseIncome	1581373	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-10710464	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-10415711	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10710464	usd
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10415711	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36742812	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27212445	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36742812	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27212445	shares
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10710464	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10415711	usd
CY2023Q3	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement	-176591	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-176591	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10887055	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10415711	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-10710464	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-10415711	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2023Q3	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	380834	usd
CY2022Q3	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	17537	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	808027	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	878640	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	37825	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	42554	usd
CY2023Q3	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture	-355877	usd
CY2022Q3	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture	-400361	usd
CY2023Q3	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	82424	usd
CY2022Q3	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	143813	usd
CY2023Q3	bivi	Realized Gain On Maturity Of Availablefor Sale RealizedGainOnMaturityOfAvailableforSale	223865	usd
CY2023Q3	bivi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets	10041	usd
CY2022Q3	bivi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets	8983	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	707802	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-566542	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1446761	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	221244	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-761499	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	179530	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10645	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-9213	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-48385	usd
CY2022Q3	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-869456	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12177049	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9220320	usd
CY2023Q3	bivi	Maturity Of U.S.Treasury Bills MaturityOfU.s.TreasuryBills	-14525000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14525000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1905836	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5903682	usd
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2500000	usd
CY2022Q3	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty	5905840	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-594164	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11809522	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1753787	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2589202	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19460883	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18641716	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21214670	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21230918	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	528541	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	469687	usd
CY2023Q3	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement	-176591	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	878640	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	17537	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5903682	usd
CY2022Q3	bivi	Proceeds From Issuance Of Common Stock Net Of Costs Of94160 Related Party ProceedsFromIssuanceOfCommonStockNetOfCostsOf94160RelatedParty	5905840	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10415711	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	5960923	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15340286	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	808027	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	380834	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1905836	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-10710464	usd
CY2023Q3	bivi	Reclassification Of Unrealized Gains On Availableforsale Investment Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentUponSettlement	-176591	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7547928	usd
CY2023Q3	bivi	Working Capital WorkingCapital	9600000	usd
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	21200000	usd
CY2023Q3	bivi	Stockholder Equities StockholderEquities	7500000	usd
CY2023Q3	bivi	Accumulated Deficit AccumulatedDeficit	311900000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12280876	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11252044	shares
CY2023	bivi	Number Of Stock Purchased NumberOfStockPurchased	46000000	usd
CY2023Q3	bivi	Realized Gain On Maturity Of Availablefor Sale RealizedGainOnMaturityOfAvailableforSale	223865	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1714019	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1656675	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	579751	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	637095	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2023Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	172033	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	229377	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	178341	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	579751	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	48000	usd
CY2023Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0850	pure
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1400000	usd
CY2023Q3	bivi	Fair Value Of Embedded Conversion Option FairValueOfEmbeddedConversionOption	2200000	usd
CY2023	bivi	Unearned Discount UnearnedDiscount	3600000	usd
CY2023Q3	bivi	Direct Financing Cost DirectFinancingCost	390000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	850000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1000000	usd
CY2023Q3	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	525000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	38000	usd
CY2023Q3	bivi	Unearned Discount UnearnedDiscount	356000	usd
CY2023Q3	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	82000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1100000	usd
CY2022Q3	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	470000	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43000	usd
CY2022Q3	bivi	Unearned Discount UnearnedDiscount	400000	usd
CY2022Q3	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	144000	usd
CY2023Q3	bivi	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	10000000	usd
CY2023Q2	bivi	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	10000000	usd
CY2023Q3	bivi	Debt Financing Costs DebtFinancingCosts	-80381	usd
CY2023Q2	bivi	Debt Financing Costs DebtFinancingCosts	-108751	usd
CY2023Q3	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	756238	usd
CY2023Q2	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	1023145	usd
CY2023Q3	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	175152	usd
CY2023Q2	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	236970	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	9338533	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	9105074	usd
CY2023Q3	bivi	Notes Payable Noncurrent NotesPayableNoncurrent	2500000	usd
CY2023Q2	bivi	Notes Payable Noncurrent NotesPayableNoncurrent	5000000	usd
CY2023Q3	bivi	Longterm Debt Financing Costs LongtermDebtFinancingCosts	-2365	usd
CY2023Q2	bivi	Longterm Debt Financing Costs LongtermDebtFinancingCosts	-11820	usd
CY2023Q3	bivi	Long Term Deferred Discounts Finance Charges And Interest Included In Receivables LongTermDeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	-22242	usd
CY2023Q2	bivi	Long Term Deferred Discounts Finance Charges And Interest Included In Receivables LongTermDeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	-111212	usd
CY2023Q3	bivi	Long Term Accretion Of Loan Premiums LongTermAccretionOfLoanPremiums	494544	usd
CY2023Q2	bivi	Long Term Accretion Of Loan Premiums LongTermAccretionOfLoanPremiums	350302	usd
CY2023Q3	bivi	Long Term Notes Payable Net Of Financing Costs Unearned Premiums And Discount LongTermNotesPayableNetOfFinancingCostsUnearnedPremiumsAndDiscount	2969937	usd
CY2023Q2	bivi	Long Term Notes Payable Net Of Financing Costs Unearned Premiums And Discount LongTermNotesPayableNetOfFinancingCostsUnearnedPremiumsAndDiscount	5227270	usd
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1112240	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1820042	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	21214670	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	33938609	usd
CY2022Q4	bivi	Total Compensation Cost TotalCompensationCost	1744192	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	596457	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.24
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	38730	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.12
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	557727	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.40
CY2023Q3	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	380834	usd
CY2022Q3	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	17537	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	13000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	13000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	70748	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80789	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	46548	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44909	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30221	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42505	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	76769	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	87414	usd
CY2023Q3	bivi	Schedule Of Future Estimated Minimum Lease Payments Under Non Cancelable Operating Leases ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases	<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases_z3Ukk6co57K1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> <span id="xdx_8BE_zQbI86v5TpG1" style="display: none">Schedule of future estimated minimum lease payments under non-cancelable operating leases</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20230930_zHmX5wcpJIi1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 87%">Year ending June 30, 2024 (Remaining 9 months)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">39,256</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"></td><td style="border-bottom: Black 1pt solid; text-align: right">44,636</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83,892</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment_iNI_pp0p0_di_zp7o4m4Ohzcc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less amount representing interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,123</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zoyt9mLcZoEg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Present value of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76,769</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_zlKihAIpICp8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion of operating lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(46,548</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zXhfkiozsmS1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Operating lease liabilities, net of current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,221</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	39256	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	44636	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	83892	usd
CY2023Q3	bivi	Capital Leases Future Minimum Payments Interest Included In Payment CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment	7123	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	76769	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	46548	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30221	usd
CY2023Q3	bivi	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	12900	usd
CY2022Q3	bivi	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	12525	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2023Q3	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	30900	usd
CY2022Q3	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	45500	usd

Files In Submission

Name	View Source	Status
bivi-20230930_cal.xml	Edgar Link	unprocessable
0001520138-23-000473-index-headers.html	Edgar Link	pending
0001520138-23-000473-index.html	Edgar Link	pending
0001520138-23-000473.txt	Edgar Link	pending
0001520138-23-000473-xbrl.zip	Edgar Link	pending
bivi-20230930.xsd	Edgar Link	pending
bivi-20230930_10q.htm	Edgar Link	pending
bivi-20230930_10qex31z1.htm	Edgar Link	pending
bivi-20230930_10qex31z2.htm	Edgar Link	pending
bivi-20230930_10qex32z1.htm	Edgar Link	pending
bivi-20230930_10qex32z2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
bivi-20230930_def.xml	Edgar Link	unprocessable
bivi-20230930_lab.xml	Edgar Link	unprocessable
bivi-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bivi-20230930_10q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIVI
BIOVIE INC. Stock $bivi

2023 Q4 Form 10-Q Financial Statement

#000152013823000473 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI BIOVIE INC. Stock $bivi

2023 Q4 Form 10-Q Financial Statement

#000152013823000473 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI
BIOVIE INC. Stock $bivi